Business Valuation Zone

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

companies biomarin-pharmaceutical-inc

Cooley, Goodwin Build BioMarin's $270M Inozyme Buy

Law 360 M&A

MAY 16, 2025

Biotechnology company BioMarin Pharmaceutical Inc., advised by Cooley LLP, on Friday announced plans to buy clinical-stage biopharmaceutical company Inozyme Pharma Inc., led by Goodwin Procter LLP, in a $270 million all-cash deal.

Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ

Benzinga

AUGUST 31, 2022

The combined company is designed to have a diversified pipeline with multiple ‘shots-on-goal' across varying indications and therapeutic areas, built from relationships with leading research institutions. The combined company will be renamed "Ocean Biomedical, Inc." NEW YORK, Aug.

Enterprise Value

Enterprise Value Technology Marketability

Cooley, Goodwin Build BioMarin's $270M Inozyme Buy

Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ

Stay Connected